Full Press Release Details
Sundial Reports Third Quarter 2021 Financial
and Operational Results
CALGARY, AB, Nov. 11, 2021 /CNW/ - Sundial Growers
Inc. (NASDAQ: SNDL) ("Sundial" or the "Company") reported its financial and operational results for the third quarter
ended September 30, 2021. All financial information in this press release is reported in millions of Canadian dollars and represents results
from continuing operations, unless otherwise indicated.
The Company will hold a conference call and webcast
at 10:30 a.m. EST (8:30 a.m. MST) on Friday, November 12, 2021. Please see the dial-in details within the release, as well as additional
details on Sundial's website at www.sndlgroup.com.
THIRD QUARTER 2021 OPERATIONAL AND INVESTMENT HIGHLIGHTS
"Our third quarter results reflect the initial
impact of the business transformation led by Sundial's team over the last 10 months," said Zach George, Chief Executive Officer of
Sundial. "We remain focused on sustainable profitability and continued improvement in all aspects of our operations. Despite the
ongoing challenges facing industry participants, our financial condition has never been stronger. Sundial is uniquely positioned relative
to its peers as we seek to delight consumers and become a trusted industry partner. Our balance sheet strength enables our team to avoid
short term pressures while working to improve the quality of our decision making. We expect that the achievement of our objectives will
result in an aggregate base business that generates free cash flow in 2022."
THIRD QUARTER 2021 KEY FINANCIAL METRICS
| OPERATING SEGMENTS | - - - - -Cannabis - - - - - | |||||||||
| ($000s) | Cultivation and Production | Retail | Investment | Corporate | Total | |||||
| As at September 30, 2021 | ||||||||||
| Total assets | 174,578 | 166,955 | 1,109,840 | 2,998 | 1,454,371 | |||||
| Nine months ended September 30, 2021 | ||||||||||
| Net revenue | 27,269 | 6,140 | 6,756 | - | 40,165 | |||||
| Gross margin | (8,149) | 3,658 | 6,756 | - | 2,265 | |||||
| Share of profit of equity-accounted investees | - | - | 13,642 | - | 13,642 | |||||
| Depreciation and amortization | 2,442 | 1,463 | - | 469 | 4,374 | |||||
| Earnings (loss) before tax | (94,800) | (476) | 17,339 | (107,542) | (185,479) | |||||
| Three months ended September 30, 2021 | ||||||||||
| Net revenue | 8,227 | 6,140 | (14,699) | - | (332) | |||||
| Gross margin | (1,876) | 3,658 | (14,699) | - | (12,917) | |||||
| Share of profit of equity-accounted investees | - | - | 9,918 | - | 9,918 | |||||
| Depreciation and amortization | 660 | 1,463 | - | 262 | 2,385 | |||||
| Earnings (loss) before tax | (10,177) | (476) | (6,012) | 17,918 | 1,253 |
Sundial reports three operating segments including
two Cannabis segments: Cultivation and production, and retail, which was added with the acquisition of Inner Spirit. The third segment
is Investments. For the three and nine months ended September 30, 2020, Cannabis was the only reportable segment, and therefore no comparative
segment information is available for the Investment or retail segments.
On October 7, 2021, the Company announced that it
had entered into an arrangement agreement with Alcanna pursuant to which the Company will acquire all of the issued and outstanding common
shares of Alcanna by way of a statutory plan of arrangement for total consideration of 387.3 million common shares of Sundial, with a
value of approximately $346 million (the "Alcanna Acquisition"). The Alcanna Acquisition is expected to close in the fourth
quarter of 2021, subject to customary closing conditions. Alcanna's longstanding liquor business provides Sundial with stable cash generation
through a mature and proven business model with trailing twelve months free cash flow of $16.4 million on a built-out retail
Alcanna is a Canadian liquor retailer, operating predominantly
in Alberta under its three retail brands, "Wine and Beyond", "Liquor Depot" and "Ace Liquor". Alcanna also
holds an approximate 63% equity interest in Nova Cannabis Inc., a Canadian cannabis retailer operating stores across Alberta, Saskatchewan,
THIRD QUARTER 2021 RESULTS
The Company's Cannabis operations are comprised of
two segments: cannabis cultivation and production and, with the acquisition of Inner Spirit, cannabis retail.
CANNABIS CULTIVATION AND PRODUCTION
Sundial remains focused and committed to optimization
of its cultivation and processing activities.
GROSS MARGIN BEFORE FAIR VALUE ADJUSTMENTS
Gross margin before fair value adjustments from cannabis cultivation and production for the three months ended September 30,
2021 was negative $4.9 million compared to negative $17.3 million for the three months ended September 30, 2020. The increase of
$12.4 million was due to a lower inventory obsolescence provision compared to the prior period as well as Sundial's ongoing focus
on cost optimization, reduction of harvest inventory subject to impairment and offering the most competitive and profitable strains and
brands to its customers against the backdrop of industry-wide price compression and high relative operating costs at our premium facility.
NET REVENUE FROM CULTIVATION AND PRODUCTION
Net revenue from cultivation and production operations in the third quarter of 2021 was $8.2 million compared to $12.9 million in
the third quarter of 2020, reflecting the Company's continuing shift to branded sales from wholesales.
Average gross selling price was $3.23 per gram in the third quarter of 2021, compared to $2.67 per gram in the third quarter of 2020.
The increase of $0.56 per gram equivalent was mainly due to an increase in prices for sales to other LPs, partially offset by lower prices
for provincial board sales. Average gross selling price per gram equivalent of branded products, net of provisions, was $3.31 per
gram in the third quarter of 2021, compared to $3.19 per gram in the second quarter of 2021.
In the third quarter of 2021 gross revenue from Sundial's formats was:
| Three months ended September 30 | Nine months ended September 30 | ||||||||||
| ($000s) | 2021 | 2020 | 2021 | 2020 | |||||||
| Revenue from dried flower | 9,273 | 11,629 | 28,763 | 39,443 | |||||||
| Revenue from vapes | 1,166 | 3,577 | 3,863 | 14,185 | |||||||
| Revenue from oil | 37 | 319 | 1,628 | 2,828 | |||||||
| Revenue from edibles and concentrates | 546 | - | 1,255 | - | |||||||
| Gross revenue | 11,022 | 15,525 | 35,509 | 56,456 |
As the cannabis industry continues to be faced by
challenges and price compression in all segments, Sundial's revenue by formats for the third quarter of 2021 has declined compared to
the third quarter of 2020. Due to a purposeful portfolio rationalization in Sundial's vape segment along
with continued price pressure, Sundial has seen a decrease in gross revenue in the third quarter of 2021.
Sundial completed its acquisition of Inner Spirit
on July 20, 2021. As a result, this is the first quarter that the Company's consolidated financial results include Inner Spirit.
| __________ |
| 1 System-wide retail sales is a non-IFRS financial measure. For more details, see the " Non-IFRS Financial Measures " section below. |
Gross margin for the period July 20 to September 30, 2021, was $3.7 million.
Sundial's investment income is classified as income
REVENUE FROM INVESTMENTS
Revenue from Investments in the third quarter of 2021
was negative $4.8 million including unrealized losses on marketable securities, due to fluctuation in share prices from our portfolio
| Three months ended September 30 | Nine months ended September 30 | ||||||||
| ($000s) | 2021 | 2020 | 2021 | 2020 | |||||
| Interest and fee revenue | |||||||||
| Interest revenue from investments at amortized cost | 352 | - | 793 | - | |||||
| Interest and fee revenue from investments at Fair Value Through Profit or Loss | 2,116 | - | 6,398 | - | |||||
| Interest revenue from cash | 841 | - | 2,311 | - | |||||
| 3,309 | - | 9,502 | - | ||||||
| Investment revenue | |||||||||
| Realized gains | 5,988 | - | 18,218 | - | |||||
| Unrealized gains (losses) | (23,996) | - | (20,964) | - | |||||
| (18,008) | - | (2,746) | - | ||||||
| Revenue from direct investments | (14,699) | - | 6,756 | - | |||||
| Share of profit of equity-accounted investees | 9,918 | - | 13,642 | - | |||||
| Total investment activities | (4,781) | - | 20,398 | - |
CONSOLIDATED FINANCIAL RESULTS
SALES, MARKETING AND GENERAL AND ADMINISTRATIVE
SMG&A costs increased by 30% from $8.3 million to $10.8 million in the third quarter of 2021 when compared to the third quarter
of 2020. The increase was mainly due to increased employee-related costs, and inclusion of Spiritleaf results subsequent to its acquisition.
Net earnings for the three months ended September 30, 2021 were $11.3 million compared to a net loss of $71.4 million in the previous
ADJUSTED EBITDA FROM CONTINUING OPERATIONS
Adjusted EBITDA from continuing operations was $10.5
million for the three months ended September 30, 2021 compared to a loss of $4.4 million for the three months ended September 30,
2020.2 The increase was due to the following:
| __________ |
| 2 Adjusted EBIDTA is a non-IFRS financial measures. For more details, see the " Non-IFRS Financial Measures " section below. |
STRATEGIC AND ORGANIZATIONAL UPDATE
Sundial remains focused on building long-term shareholder
value through the accretive deployment of cash resources and on achieving sustainable profitability through a streamlined and right-sized
operating structure, and on enhanced offering of high-quality brands.
The Company continues to monitor daily developments
in the COVID-19 pandemic and actions taken by government authorities. In accordance with the guidance of provincial and federal health
officials to limit the risk and transmission of COVID-19, Sundial continues to implement mandatory self-quarantine policies,
travel restrictions, enhanced cleaning and sanitation processes and frequency, safety shields at its retail outlets and social distancing
measures. Sundial believes that it has maintained and can maintain safe operations with these pandemic-related procedures and protocols
in place. The Company has not experienced a material impact on its production and processing activities to date related to COVID-19.
Certain financial measures in this news release, including
adjusted EBITDA from continuing operations, gross margin before fair value adjustments, and system-wide retail sales are non-IFRS measures.
These terms are not defined by IFRS and, therefore, may not be comparable to similar measures provided by other companies. These non-IFRS
financial measures should not be considered in isolation or as an alternative for measures of performance prepared in accordance with
ADJUSTED EBITDA FROM CONTINUING OPERATIONS
Adjusted EBITDA from continuing operations is a non-IFRS measure which the Company uses to evaluate its operating performance.
Adjusted EBITDA from continuing operations provides information to investors, analysts and others to aid in understanding
and evaluating the Company's operating results in a similar manner to its management team. Adjusted EBITDA from continuing
operations is defined as net income (loss) from continuing operations before finance costs, depreciation and amortization, accretion expense,
income tax recovery and excluding change in fair value of biological assets, change in fair value realized through inventory, unrealized
foreign exchange gains or losses, unrealized gains or losses on marketable securities, change in fair value of derivative warrants, share-based
compensation expense, asset impairment, gain or loss on disposal of property, plant and equipment and certain one-time non-operating expenses,
as determined by management.
| ($000s except percentages) | Q3 2021 | Q2 2021 | % Change | Q3 2020 | % Change | |
| Net income (loss) from continuing operations | 11,311 | (52,287) | 122% | (71,397) | 116% | |
| Adjustments | ||||||
| Finance costs | 135 | 40 | 238% | (8,139) | 102% | |
| Change in estimate of fair value of derivative warrants | (24,100) | (19,810) | -22% | (10,058) | -140% | |
| Depreciation and amortization | 2,385 | 931 | 156% | 1,480 | 61% | |
| Income tax recovery | (10,058) | - | 100% | - | 100% | |
| Change in fair value of biological assets | (2,975) | 331 | 999% | (194) | -1434% | |
| Change in fair value realized through inventory | (15) | 456 | 103% | 2,447 | 101% | |
| Unrealized foreign exchange (gain) loss | (2,071) | 104 | 2091% | (243) | -752% | |
| Unrealized (gain) loss on marketable securities | 23,996 | 1,849 | 1198% | - | 100% | |
| Share-based compensation | 1,869 | 4,539 | -59% | 3,118 | -40% | |
| Asset impairment | - | 60,000 | -100% | 60,000 | -100% | |
| Loss (gain) on disposition of PP&E | - | 22 | -100% | - | 0% | |
| Cost of sales non-cash component (1) | 915 | 1,162 | -21% | 1,289 | -29% | |
| Inventory obsolescence | 3,871 | 1,651 | 134% | 19,897 | -81% | |
| Restructuring costs | - | - | 0% | 1,108 | -100% | |
| Transaction costs (2) | 5,276 | 805 | 555% | 364 | 1349% | |
| Government subsidies | - | - | 0% | (4,081) | -100% | |
| Other expenses | - | 2 | -100% | - | 0% | |
| Adjusted EBITDA from continuing operations | 10,539 | (205) | 5241% | (4,409) | 339% | |
| (1) Cost of sales non-cash component is comprised of depreciation expense | ||||||
| (2) Transaction costs relate to financing activities |